These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 21831031)

  • 1. Gender differences in metabolic syndrome: a key research issue?
    Iyer A; Kauter K; Brown L
    Endocr Metab Immune Disord Drug Targets; 2011 Sep; 11(3):182-8. PubMed ID: 21831031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targets for research in the metabolic syndrome.
    Brown L
    Endocr Metab Immune Disord Drug Targets; 2011 Sep; 11(3):181. PubMed ID: 21651475
    [No Abstract]   [Full Text] [Related]  

  • 3. Research advances in metabolism 2016.
    Perakakis N; Farr OM; Tuccinardi D; Upadhyay J; Mantzoros CS
    Metabolism; 2017 Feb; 67():41-53. PubMed ID: 28081777
    [No Abstract]   [Full Text] [Related]  

  • 4. JAK/STAT - Emerging Players in Metabolism.
    Dodington DW; Desai HR; Woo M
    Trends Endocrinol Metab; 2018 Jan; 29(1):55-65. PubMed ID: 29191719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of the thioredoxin/thioredoxin reductase system in the metabolic syndrome: towards a possible prognostic marker?
    Tinkov AA; Bjørklund G; Skalny AV; Holmgren A; Skalnaya MG; Chirumbolo S; Aaseth J
    Cell Mol Life Sci; 2018 May; 75(9):1567-1586. PubMed ID: 29327078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contributory Risk and Management of Comorbidities of Hypertension, Obesity, Diabetes Mellitus, Hyperlipidemia, and Metabolic Syndrome in Chronic Heart Failure: A Scientific Statement From the American Heart Association.
    Bozkurt B; Aguilar D; Deswal A; Dunbar SB; Francis GS; Horwich T; Jessup M; Kosiborod M; Pritchett AM; Ramasubbu K; Rosendorff C; Yancy C;
    Circulation; 2016 Dec; 134(23):e535-e578. PubMed ID: 27799274
    [No Abstract]   [Full Text] [Related]  

  • 7. Characterization and Functions of Protease-Activated Receptor 2 in Obesity, Diabetes, and Metabolic Syndrome: A Systematic Review.
    Kagota S; Maruyama K; McGuire JJ
    Biomed Res Int; 2016; 2016():3130496. PubMed ID: 27006943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammation and oxidative stress in obesity, metabolic syndrome, and diabetes.
    Galassetti P
    Exp Diabetes Res; 2012; 2012():943706. PubMed ID: 23319940
    [No Abstract]   [Full Text] [Related]  

  • 9. Gender disparity in outcomes of care and management for diabetes and the metabolic syndrome.
    Sarafidis PA; McFarlane SI; Bakris GL
    Curr Diab Rep; 2006 Jun; 6(3):219-24. PubMed ID: 16898575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging Therapeutic Targets for Metabolic Syndrome: Lessons from Animal Models.
    Singh H; Pragasam SJ; Venkatesan V
    Endocr Metab Immune Disord Drug Targets; 2019; 19(4):481-489. PubMed ID: 30499422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic Syndrome: Sex-Related Cardiovascular Risk and Therapeutic Approach.
    Santilli F; D'Ardes D; Guagnano MT; Davi G
    Curr Med Chem; 2017; 24(24):2602-2627. PubMed ID: 28699503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exercise training dose differentially alters muscle and heart capillary density and metabolic functions in an obese rat with metabolic syndrome.
    Machado MV; Vieira AB; da Conceição FG; Nascimento AR; da Nóbrega ACL; Tibirica E
    Exp Physiol; 2017 Dec; 102(12):1716-1728. PubMed ID: 28921743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The equine metabolic syndrome peripheral Cushing's syndrome.
    Johnson PJ
    Vet Clin North Am Equine Pract; 2002 Aug; 18(2):271-93. PubMed ID: 15635908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [113th Scientific Meeting of the Japanese Society of Internal Medicine: Presidential Lecture: Panel Discussion: Obesity Disease and Metabolic Syndrome -from Pathophysiology to Concept of Management: Introduction].
    Matsuzawa Y; Kasuga M
    Nihon Naika Gakkai Zasshi; 2016 Sep; 105(9):1626. PubMed ID: 30169922
    [No Abstract]   [Full Text] [Related]  

  • 15. Sex- and gender-related prevalence, cardiovascular risk and therapeutic approach in metabolic syndrome: A review of the literature.
    Pucci G; Alcidi R; Tap L; Battista F; Mattace-Raso F; Schillaci G
    Pharmacol Res; 2017 Jun; 120():34-42. PubMed ID: 28300617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the ZDSD Rat: A Translational Model for the Study of Metabolic Syndrome and Type 2 Diabetes.
    Peterson RG; Jackson CV; Zimmerman K; de Winter W; Huebert N; Hansen MK
    J Diabetes Res; 2015; 2015():487816. PubMed ID: 25961053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testosterone a key factor in gender related metabolic syndrome.
    Bianchi VE; Locatelli V
    Obes Rev; 2018 Apr; 19(4):557-575. PubMed ID: 29356299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dyslipidemia in the metabolic syndrome in children.
    Gidding SS
    J Cardiometab Syndr; 2006; 1(4):282-5. PubMed ID: 17679808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic syndrome and cardiovascular health: a look beyond the horizon.
    Zhang Y; Ren J
    Curr Pharm Des; 2013; 19(27):4797-8. PubMed ID: 23844872
    [No Abstract]   [Full Text] [Related]  

  • 20. Where are we now in diabetic research?
    Kwak MK; Ha H
    Arch Pharm Res; 2013 Feb; 36(2):142-4. PubMed ID: 23377709
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.